Correctors Rescue CFTR Mutations in Nucleotide-Binding Domain 1 (NBD1) by Modulating Proteostasis

Miquéias Lopes-Pacheco, Inna Sabirzhanova, Daniele Rapino, Marcelo M. Morales, William B Guggino, Liudmila Cebotaru

Research output: Contribution to journalArticle

Abstract

We evaluated whether small molecule correctors could rescue four nucleotide-binding domain1 (NBD1) mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (A455E, S492F, ΔI507, and R560T). We first transfected Cos-7 cells (green monkey kidney cells) with A455E, S492F, ΔI507, or R560T and created HEK-293 (human embryonic kidney cells) cell lines stably expressing these CFTR mutations. The mutants showed lowered protein expression, instability at physiological temperature, and rapid degradation. After treatment with correctors CFFT-002, CFFT-003, C3, C4, and/or C18, the combination of C18+C4 showed the most correction and resulted in increased CFTR residing in the plasma membrane. We found a profound decrease in binding of CFTR to histone deacetylases (HDAC) 6 and 7 and heat shock proteins (Hsps) 27 and 40. Silencing Hsp27 or 40 rescued the mutants, but no additional amount of CFTR was rescued when both proteins were knocked down simultaneously. Thus, CFTR mutations in NBD1 can be rescued by a combination of correctors, and the treatment alters the interaction between mutated CFTR and the endoplasmic reticulum machinery.

Original languageEnglish (US)
JournalChemBioChem
DOIs
StateAccepted/In press - 2016

Fingerprint

Cystic Fibrosis Transmembrane Conductance Regulator
Nucleotides
Mutation
HSP40 Heat-Shock Proteins
HSP27 Heat-Shock Proteins
Kidney
Cercopithecus aethiops
Histone Deacetylases
Cell membranes
Regulator Genes
Endoplasmic Reticulum
Machinery
Proteins
Genes
Cells
Cell Membrane
Cell Line
Degradation
Molecules
Temperature

Keywords

  • Correctors
  • Cystic fibrosis
  • Mutagenesis
  • Protein misfolding
  • Proteostasis network

ASJC Scopus subject areas

  • Biochemistry
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology

Cite this

Correctors Rescue CFTR Mutations in Nucleotide-Binding Domain 1 (NBD1) by Modulating Proteostasis. / Lopes-Pacheco, Miquéias; Sabirzhanova, Inna; Rapino, Daniele; Morales, Marcelo M.; Guggino, William B; Cebotaru, Liudmila.

In: ChemBioChem, 2016.

Research output: Contribution to journalArticle

Lopes-Pacheco, Miquéias ; Sabirzhanova, Inna ; Rapino, Daniele ; Morales, Marcelo M. ; Guggino, William B ; Cebotaru, Liudmila. / Correctors Rescue CFTR Mutations in Nucleotide-Binding Domain 1 (NBD1) by Modulating Proteostasis. In: ChemBioChem. 2016.
@article{da5a5b9ed0c14160bc11df7dd85b3017,
title = "Correctors Rescue CFTR Mutations in Nucleotide-Binding Domain 1 (NBD1) by Modulating Proteostasis",
abstract = "We evaluated whether small molecule correctors could rescue four nucleotide-binding domain1 (NBD1) mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (A455E, S492F, ΔI507, and R560T). We first transfected Cos-7 cells (green monkey kidney cells) with A455E, S492F, ΔI507, or R560T and created HEK-293 (human embryonic kidney cells) cell lines stably expressing these CFTR mutations. The mutants showed lowered protein expression, instability at physiological temperature, and rapid degradation. After treatment with correctors CFFT-002, CFFT-003, C3, C4, and/or C18, the combination of C18+C4 showed the most correction and resulted in increased CFTR residing in the plasma membrane. We found a profound decrease in binding of CFTR to histone deacetylases (HDAC) 6 and 7 and heat shock proteins (Hsps) 27 and 40. Silencing Hsp27 or 40 rescued the mutants, but no additional amount of CFTR was rescued when both proteins were knocked down simultaneously. Thus, CFTR mutations in NBD1 can be rescued by a combination of correctors, and the treatment alters the interaction between mutated CFTR and the endoplasmic reticulum machinery.",
keywords = "Correctors, Cystic fibrosis, Mutagenesis, Protein misfolding, Proteostasis network",
author = "Miqu{\'e}ias Lopes-Pacheco and Inna Sabirzhanova and Daniele Rapino and Morales, {Marcelo M.} and Guggino, {William B} and Liudmila Cebotaru",
year = "2016",
doi = "10.1002/cbic.201500620",
language = "English (US)",
journal = "ChemBioChem",
issn = "1439-4227",
publisher = "Wiley-VCH Verlag",

}

TY - JOUR

T1 - Correctors Rescue CFTR Mutations in Nucleotide-Binding Domain 1 (NBD1) by Modulating Proteostasis

AU - Lopes-Pacheco, Miquéias

AU - Sabirzhanova, Inna

AU - Rapino, Daniele

AU - Morales, Marcelo M.

AU - Guggino, William B

AU - Cebotaru, Liudmila

PY - 2016

Y1 - 2016

N2 - We evaluated whether small molecule correctors could rescue four nucleotide-binding domain1 (NBD1) mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (A455E, S492F, ΔI507, and R560T). We first transfected Cos-7 cells (green monkey kidney cells) with A455E, S492F, ΔI507, or R560T and created HEK-293 (human embryonic kidney cells) cell lines stably expressing these CFTR mutations. The mutants showed lowered protein expression, instability at physiological temperature, and rapid degradation. After treatment with correctors CFFT-002, CFFT-003, C3, C4, and/or C18, the combination of C18+C4 showed the most correction and resulted in increased CFTR residing in the plasma membrane. We found a profound decrease in binding of CFTR to histone deacetylases (HDAC) 6 and 7 and heat shock proteins (Hsps) 27 and 40. Silencing Hsp27 or 40 rescued the mutants, but no additional amount of CFTR was rescued when both proteins were knocked down simultaneously. Thus, CFTR mutations in NBD1 can be rescued by a combination of correctors, and the treatment alters the interaction between mutated CFTR and the endoplasmic reticulum machinery.

AB - We evaluated whether small molecule correctors could rescue four nucleotide-binding domain1 (NBD1) mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (A455E, S492F, ΔI507, and R560T). We first transfected Cos-7 cells (green monkey kidney cells) with A455E, S492F, ΔI507, or R560T and created HEK-293 (human embryonic kidney cells) cell lines stably expressing these CFTR mutations. The mutants showed lowered protein expression, instability at physiological temperature, and rapid degradation. After treatment with correctors CFFT-002, CFFT-003, C3, C4, and/or C18, the combination of C18+C4 showed the most correction and resulted in increased CFTR residing in the plasma membrane. We found a profound decrease in binding of CFTR to histone deacetylases (HDAC) 6 and 7 and heat shock proteins (Hsps) 27 and 40. Silencing Hsp27 or 40 rescued the mutants, but no additional amount of CFTR was rescued when both proteins were knocked down simultaneously. Thus, CFTR mutations in NBD1 can be rescued by a combination of correctors, and the treatment alters the interaction between mutated CFTR and the endoplasmic reticulum machinery.

KW - Correctors

KW - Cystic fibrosis

KW - Mutagenesis

KW - Protein misfolding

KW - Proteostasis network

UR - http://www.scopus.com/inward/record.url?scp=84975770275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975770275&partnerID=8YFLogxK

U2 - 10.1002/cbic.201500620

DO - 10.1002/cbic.201500620

M3 - Article

JO - ChemBioChem

JF - ChemBioChem

SN - 1439-4227

ER -